COVID-19
As of 9 Dec 2022, 12:00pm
Hospitalised
137
18
Required Oxygen Supplementation
5
ICU
New Cases
1,017
7-day Moving Average of Local Cases
1,809
Discharged
0
Died
0.96
Week on Week Infection Ratio
Over the last 28 days,
Infected
36,666
99.6%
Had No or Mild Symptoms
0.30%
0.04%
0.01%
As of 8 Dec 2022 (COVID-19 vaccines under National Vaccination Programme only)
82% of eligible population
has minimum protection
65% of eligible population
has up-to-date vaccination
Total Cases
2,179,044
1,707
Total Deaths
The bivalent Pfizer-BioNTech/Comirnaty COVID-19 vaccine will be available from 12 Dec 2022 for primary series and boosters, for persons 12 years and above.The bivalent Moderna/Spikevax vaccine continues to be available for persons aged 18 years and above.To keep up to date with their COVID-19 vaccination, persons aged 12 to 17 years old should receive an additional bivalent dose around 5 months after their last booster dose.From 12 Dec 2022, mobile vaccination teams (MVTs) will be deployed to a number of heartland locations. Find out more here.
As reinfections become more common, those who experience symptoms like cough, sore throat, runny nose or fever, after 28 days from their previous infection, should test themselves for COVID-19.
More details
From 7 Nov 2022, eligible individuals aged 18 to 49 years will be invited to receive an additional dose of the Moderna/Spikevax bivalent vaccine, starting with the 40 to 49 age group.
From 12 Dec 2022, the bivalent Pfizer-BioNTech/Comirnaty vaccine will be available for primary series and boosters for those 12 years and above.
Read more
Safe Management Measures
View the full list of community measures, effective 10 October 2022.
Healthcare Schemes & Subsidies
View the different healthcare financing schemes & subsidies, e.g. MediShield Life, CareShield Life, CHAS.
Falsehoods & Clarifications
Verify the authenticity of COVID-19-related news and information. Beware of false and misleading statements.
07 Dec 2022
SINGAPORE CONTRIBUTES USD1 MILLION TO THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA
06 Dec 2022
EXPERT COMMITTEE ON COVID-19 VACCINATION UPDATES RECOMMENDATIONS FOR THE PFIZER-BIONTECH/COMIRNATY C...
BIVALENT PFIZER-BIONTECH/COMIRNATY VACCINATION TO START FROM 12 DECEMBER 2022
Follow us now for daily updates
View this post on Instagram A post shared by Ministry of Health, Singapore (@moh_singapore)
A post shared by Ministry of Health, Singapore (@moh_singapore)
Healthier You, with Healthier SG
Second Booster for Seniors Aged 80 and above
Thank you Healthcare Workers
The Health Promotion Board (HPB) is a government organisation committed to promoting healthy living in Singapore. HPB is a credible and authoritative source of evidence-based health information that seeks to empower the Singapore public with knowledge to take ownership of their health and live a healthy lifestyle.
The Health Sciences Authority (HSA) was formed on 1 April 2001 as a statutory board of the Singapore Ministry of Health with the integration of five specialised agencies. Its vision is to be the leading innovative authority protecting and advancing national health and safety.
The National Healthcare Group (NHG) is a leader in public healthcare in Singapore, recognised at home and abroad for the quality of its medical expertise and facilities. Care is provided through an integrated network of six primary care polyclinics, acute care and tertiary hospitals, national specialty centres and business divisions. Together NHG bring a rich legacy of medical expertise to their philosophy of integrated patient-centred care.
The National University Health System (NUHS) is one of three public healthcare clusters in Singapore, and an integrated Academic Health System and Regional Health System that delivers value-driven, innovative and sustainable healthcare in Singapore.
With a network of acute hospitals, national specialty centres, community hospitals and polyclinics offering over 40 clinical specialties, the SingHealth Duke-NUS Academic Medical Centre draws on the collective strengths of SingHealth and Duke-NUS Medical School to drive the transformation of healthcare and provide affordable, accessible and quality healthcare.
The Singapore Dental Council (SDC) is the self-regulatory body for the dental professions constituted under the Dental Registration Act (Chapter 76). Its key objectives are to promote high standards of oral health and to promote the interests of the dental profession in Singapore.
The Singapore Medical Council (SMC), a statutory board under the Ministry of Health, maintains the Register of Medical Practitioners in Singapore, administers the compulsory continuing medical education (CME) programme and also governs and regulates the professional conduct and ethics of registered medical practitioners.
The Singapore Nursing Board (SNB) is the regulatory authority for nurses and midwives in Singapore. They aim to protect the public through licensure and regulation of nursing/midwifery education and practice. Their mission is to uphold professional nursing standards and honour the public trust.
The Singapore Pharmacy Council (SPC) maintains the list of persons legally qualified to practise pharmacy in Singapore (Register of Pharmacist) and also governs and regulates the professional conduct and ethics of registered pharmacists, ensuring that pharmacists are current in pharmaceutical knowledge and skills.
The Traditional Chinese Medicine Practitioners Board (TCMPB) registers TCM practitioners (both acupuncturists and TCM physicians), accredits TCM institutions and TCM courses for the purpose of registration and regulates the professional ethics and conduct of registered TCM practitioners.